Candoro ethics GmbH
DEM1202.HRB16199
Firmensitz
Marie-Curie-Str. 11
61381 Friedrichsdorf
Hessen
Deutschland
Kontakt
Geschäftsführung
Andreas Christian Eberhorn
Managing Director
Seit 24. Januar 2023
Andreas Christian Eberhorn
Managing Director
Seit 25. April 2023
Hans-Georg Feldmeier
Managing Director
Seit 6. April 2022
Hans-Georg Feldmeier
Managing Director
Seit 25. April 2023
David Clifford PryceEhemalig
Managing Director
4. Juni 2019 – 31. Januar 2020
Erik StorgaardEhemalig
Managing Director
10. Oktober 2019 – 13. Oktober 2020
Franziska Ingeborg BezoldEhemalig
Managing Director
29. August 2023 – 30. Oktober 2023
Georg Sebastian RiedmayrEhemalig
Managing Director
18. Mai 2021 – 22. Juni 2021
Mark Anthony Nicholas ZekulinEhemalig
Managing Director
27. August 2019 – 31. Januar 2020
Michael A. PoppEhemalig
Managing Director
30. Juli 2014 – 4. Juni 2019
Michael RödelEhemalig
Managing Director
30. Juli 2014 – 4. Juni 2019
Paul Leopold StecklerEhemalig
Managing Director
10. Oktober 2019 – 25. März 2022
Phillip Stephen Trustee de Shaer Family Trust ShaerEhemalig
Managing Director
27. August 2019 – 31. Januar 2020
Pierre Charles DebsEhemalig
Managing Director
4. Juni 2019 – 10. Oktober 2019
Silvia OttEhemalig
Managing Director
25. März 2022 – 24. Januar 2023
Tejinder VirkEhemalig
Managing Director
4. Juni 2019 – 10. Oktober 2019
Trine Katborg DavidsenEhemalig
Managing Director
31. Januar 2020 – 25. März 2022
Uwe BaumannEhemalig
Managing Director
11. März 2016 – 4. Juni 2019
Finanzen
| Jahr | Umsatz | Gewinn | Bilanzsumme | Eigenkapitalquote |
|---|---|---|---|---|
| 2024 | ~72.000.000 € | -10.319.000 € | 23.688.000 € | 773.1% |
| 2023 | ~160.000.000 € | -2.907.900 € | 39.882.794 € | 77.4% |
| 2022 | ~160.000.000 € | -2.510.252 € | 46.713.912 € | 72.3% |
Branche
NACE 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Rohdaten
{
"id": "8ed5ff33-3346-4546-827f-630bbd448ed7",
"euId": "DEM1202.HRB16199",
"name": "Candoro ethics GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2023-04-25T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Marie-Curie-Str. 11",
"city": "Friedrichsdorf",
"zipCode": "61381",
"state": "HE",
"country": "DE",
"latitude": 50.2535036,
"longitude": 8.6600128
},
"contactData": {
"emails": [
"info@candoro.de"
],
"phones": [],
"websites": [],
"faxes": []
},
"managers": [
{
"name": "Andreas Christian Eberhorn",
"position": "Managing Director",
"startDate": "2023-01-24T00:00:00",
"endDate": null
},
{
"name": "Andreas Christian Eberhorn",
"position": "Managing Director",
"startDate": "2023-04-25T00:00:00",
"endDate": null
},
{
"name": "David Clifford Pryce",
"position": "Managing Director",
"startDate": "2019-06-04T00:00:00",
"endDate": "2020-01-31T00:00:00"
},
{
"name": "Erik Storgaard",
"position": "Managing Director",
"startDate": "2019-10-10T00:00:00",
"endDate": "2020-10-13T00:00:00"
},
{
"name": "Franziska Ingeborg Bezold",
"position": "Managing Director",
"startDate": "2023-08-29T00:00:00",
"endDate": "2023-10-30T00:00:00"
},
{
"name": "Georg Sebastian Riedmayr",
"position": "Managing Director",
"startDate": "2021-05-18T00:00:00",
"endDate": "2021-06-22T00:00:00"
},
{
"name": "Hans-Georg Feldmeier",
"position": "Managing Director",
"startDate": "2022-04-06T00:00:00",
"endDate": null
},
{
"name": "Hans-Georg Feldmeier",
"position": "Managing Director",
"startDate": "2023-04-25T00:00:00",
"endDate": null
},
{
"name": "Mark Anthony Nicholas Zekulin",
"position": "Managing Director",
"startDate": "2019-08-27T00:00:00",
"endDate": "2020-01-31T00:00:00"
},
{
"name": "Michael A. Popp",
"position": "Managing Director",
"startDate": "2014-07-30T00:00:00",
"endDate": "2019-06-04T00:00:00"
},
{
"name": "Michael Rödel",
"position": "Managing Director",
"startDate": "2014-07-30T00:00:00",
"endDate": "2019-06-04T00:00:00"
},
{
"name": "Paul Leopold Steckler",
"position": "Managing Director",
"startDate": "2019-10-10T00:00:00",
"endDate": "2022-03-25T00:00:00"
},
{
"name": "Phillip Stephen Trustee de Shaer Family Trust Shaer",
"position": "Managing Director",
"startDate": "2019-08-27T00:00:00",
"endDate": "2020-01-31T00:00:00"
},
{
"name": "Pierre Charles Debs",
"position": "Managing Director",
"startDate": "2019-06-04T00:00:00",
"endDate": "2019-10-10T00:00:00"
},
{
"name": "Silvia Ott",
"position": "Managing Director",
"startDate": "2022-03-25T00:00:00",
"endDate": "2023-01-24T00:00:00"
},
{
"name": "Tejinder Virk",
"position": "Managing Director",
"startDate": "2019-06-04T00:00:00",
"endDate": "2019-10-10T00:00:00"
},
{
"name": "Trine Katborg Davidsen",
"position": "Managing Director",
"startDate": "2020-01-31T00:00:00",
"endDate": "2022-03-25T00:00:00"
},
{
"name": "Uwe Baumann",
"position": "Managing Director",
"startDate": "2016-03-11T00:00:00",
"endDate": "2019-06-04T00:00:00"
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": []
},
"financials": [
{
"year": 2022,
"currency": "EUR",
"capital": 3183340,
"capitalIsEstimate": false,
"balanceTotal": 46713912.25,
"balanceTotalIsEstimate": false,
"earnings": -2510251.9,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 160000000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": -1.5689074375,
"returnOnSalesIsEstimate": true,
"equity": 33769395.68,
"equityIsEstimate": false,
"equityRatio": 72.28980415786091,
"equityRatioIsEstimate": false,
"cash": 5527794.79,
"cashIsEstimate": false,
"receivables": 24480973.34,
"receivablesIsEstimate": false,
"liabilities": 12944516.57,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 3183340,
"capitalIsEstimate": false,
"balanceTotal": 39882794.13,
"balanceTotalIsEstimate": false,
"earnings": -2907899.65,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 160000000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": -1.81743728125,
"returnOnSalesIsEstimate": true,
"equity": 30861496.03,
"equityIsEstimate": false,
"equityRatio": 77.38047622592686,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 25737055.4,
"receivablesIsEstimate": false,
"liabilities": 8568564.77,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 3183340,
"capitalIsEstimate": false,
"balanceTotal": 23688000,
"balanceTotalIsEstimate": false,
"earnings": -10319000,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 72000000,
"revenueIsEstimate": true,
"revenueCagr": -55.00000000000001,
"revenueCagrIsEstimate": true,
"returnOnSales": -14.331944444444444,
"returnOnSalesIsEstimate": true,
"equity": 183142000,
"equityIsEstimate": false,
"equityRatio": 773.1425194191152,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 6565000,
"receivablesIsEstimate": false,
"liabilities": 350000,
"liabilitiesIsEstimate": false
}
]
}